further study of melphalan in pediatric tumors may be warranted in special circumstances : in higher doses ( greater than 100 mg/m2 ) as cytoreduction therapy for specific cancers with marrow rescue , or as part of combination therapy in certain cancers ( eg , lymphoma , sarcoma ) , possibly at doses of 20 to 30 mg/m2 every 4 weeks .
C0006826
cancers
C0024299
lymphoma